Michael R. Palovich

790 citations

22 papers · 515 indexed · h-index 14

Co-authors: James A. Marshall Dennis P. Curran Ulf Diederichsen Miriam Burman Henry M. Sarau James J. Foley Darren V. S. Green Anthony J. Taylor
Topics: Receptor Mechanisms and Signaling (9 papers)Chemokine receptors and signaling (4 papers)Neuropeptides and Animal Physiology (4 papers)
Cited by: Organic Chemistry Toxicology Pharmaceutical Science
Journals: Journal of the American Chemical Society The Journal of Physiology Journal of Medicinal Chemistry
Partner nations: United States United Kingdom Australia

In The Last Decade

Michael R. Palovich

22 papers receiving 487 citations

Peers

Countries citing papers authored by Michael R. Palovich

Since Specialization

Citations

This map shows the geographic impact of Michael R. Palovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Palovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Palovich more than expected).

Fields of papers citing papers by Michael R. Palovich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Palovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Palovich. The network helps show where Michael R. Palovich may publish in the future.

Co-authorship network of co-authors of Michael R. Palovich

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Palovich. A scholar is included among the top collaborators of Michael R. Palovich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Palovich. Michael R. Palovich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adapting drug discovery to Artificial Intelligence 2018 ·George Okafo,Ami S. Lakdawala,(unknown),John Baldoni,Michael R. Palovich,Tobias Sikosek	8
2	Quality guidelines for oral drug candidates: dose, solubility and lipophilicity 2016 ·Drug Discovery Today ·Martin K. Bayliss,James Butler,Paul L. Feldman,Darren V. S. Green,Paul D. Leeson,Michael R. Palovich,Anthony J. Taylor	82
3	Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases 2013 ·Journal of Pharmacology and Experimental Therapeutics ·M Salmon,Mark A. Luttmann,James J. Foley,Peter T. Buckley,Dulcie B. Schmidt,Miriam Burman,Edward F. Webb,(unknown),Charles J. Kotzer,Victoria J. Barrett,Robert J. Slack,Henry M. Sarau,Michael R. Palovich,Dramane I. Lainé,Douglas W.P. Hay,William L. Rumsey	64
4	Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups 2012 ·Bioorganic & Medicinal Chemistry Letters ·Qi Jin,(unknown),(unknown),Jian Jin,Yonghui Wang,Katherine L. Widdowson,Michael R. Palovich,James J. Foley,Dulcie B. Schmidt,Peter T. Buckley,Edward F. Webb,M Salmon,Kristen E. Belmonte,Henry M. Sarau,Jakob Busch‐Petersen	3
5	Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD 2009 ·Bioorganic & Medicinal Chemistry Letters ·Zehong Wan,Dramane I. Lainé,Hongxing Yan,(unknown),Katherine L. Widdowson,Peter T. Buckley,Miriam Burman,James J. Foley,Henry M. Sarau,Dulcie B. Schmidt,Edward F. Webb,Kristen E. Belmonte,Michael R. Palovich	2
6	Design, Synthesis, and Structure−Activity Relationship of Tropane Muscarinic Acetylcholine Receptor Antagonists 2009 ·Journal of Medicinal Chemistry ·Dramane I. Lainé,Zehong Wan,Hongxing Yan,(unknown),Haibo Xie,Wei Fu,Jakob Busch‐Petersen,(unknown),(unknown),Katherine L. Widdowson,Frank E. Blaney,James J. Foley,(unknown),Edward F. Webb,Mark A. Luttmann,Miriam Burman,Henry M. Sarau,M Salmon,Michael R. Palovich,Kristen E. Belmonte	9
7	M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Yonghui Wang,(unknown),Feng Wang,Haibo Xie,Zehong Wan,(unknown),James J. Foley,Parvathi Nuthulaganti,Lorena A. Kallal,Henry M. Sarau,Dwight M. Morrow,M. Lane Moore,Ralph A. Rivero,Michael R. Palovich,M Salmon,Kristen E. Belmonte,Dramane I. Lainé,Jian Jin	4
8	Discovery of Novel 1-Azoniabicyclo[2.2.2]octane Muscarinic Acetylcholine Receptor Antagonists 2009 ·Journal of Medicinal Chemistry ·Dramane I. Lainé,(unknown),(unknown),(unknown),(unknown),Jérémy Dufour,Katherine L. Widdowson,Michael R. Palovich,Frank E. Blaney,James J. Foley,Edward F. Webb,Mark A. Luttmann,Miriam Burman,Kristen E. Belmonte,M Salmon	16
9	Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas 2008 ·Bioorganic & Medicinal Chemistry Letters ·Jian Jin,Yonghui Wang,(unknown),Feng Wang,Wei Fu,(unknown),Qi Jin,James J. Foley,Henry M. Sarau,Dwight M. Morrow,Michael L. Moore,Ralph A. Rivero,Michael R. Palovich,M Salmon,Kristen E. Belmonte,Jakob Busch‐Petersen	2
10	Discovery of Biphenyl Piperazines as Novel and Long Acting Muscarinic Acetylcholine Receptor Antagonists 2008 ·Journal of Medicinal Chemistry ·Jian Jin,(unknown),Yonghui Wang,(unknown),Feng Wang,Haibo Xie,Zehong Wan,(unknown),James J. Foley,Edward F. Webb,(unknown),Miriam Burman,Henry M. Sarau,Dwight M. Morrow,M. Lane Moore,Ralph A. Rivero,Michael R. Palovich,M Salmon,Kristen E. Belmonte,Dramane I. Lainé	13
11	3-Arylamino-2H-1,2,4-benzothiadiazin-5-ol 1,1-dioxides as novel and selective CXCR2 antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Yonghui Wang,Jakob Busch‐Petersen,Feng Wang,Lanping Ma,(unknown),Jeffrey K. Kerns,Jian Jin,Michael R. Palovich,Jingkang Shen,Miriam Burman,James J. Foley,Dulcie B. Schmidt,(unknown),Henry M. Sarau,Katherine L. Widdowson	25
12	Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Dramane I. Lainé,Haibo Xie,(unknown),James J. Foley,Peter T. Buckley,Edward F. Webb,Katherine L. Widdowson,Michael R. Palovich,Kristen E. Belmonte	7
13	N,N′-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Hong Nie,Katherine L. Widdowson,Michael R. Palovich,(unknown),John D. Elliott,Deborah Bryan,Miriam Burman,Dulcie B. Schmidt,James J. Foley,Henry M. Sarau,Jakob Busch‐Petersen	21
14	Comparison of N,N′-diarylsquaramides and N,N′-diarylureas as antagonists of the CXCR2 chemokine receptor 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Michael R. Palovich,Katherine L. Widdowson,(unknown),Miriam Burman,James J. Foley,Dulcie B. Schmidt,Henry M. Sarau,Martin Rogers,Kevin L. Salyers,Peter D. Gorycki,Theresa J. Roethke,(unknown),Leonard M. Azzarano,Keith W. Ward,Jakob Busch‐Petersen	32
15	Fluorescent styryl dyes FM1‐43 and FM2‐10 are muscarinic receptor antagonists: intravital visualization of receptor occupancy 2006 ·The Journal of Physiology ·Stuart B. Mazzone,Nanako Mori,Miriam Burman,Michael R. Palovich,Kristen E. Belmonte,Brendan J. Canning	17
16	Discovery of potent and orally bioavailable N,N′-diarylurea antagonists for the CXCR2 chemokine receptor 2004 ·Bioorganic & Medicinal Chemistry Letters ·Qi Jin,Hong Nie,(unknown),Katherine L. Widdowson,Michael R. Palovich,John D. Elliott,(unknown),Miriam Burman,Henry M. Sarau,Keith W. Ward,(unknown),(unknown),Peter D. Gorycki,Jakob Busch‐Petersen	32
17	Enantioselective and Diastereoselective Additions of Allylic Stannanes to Aldehydes Promoted by a Chiral (Acyloxy)borane Catalyst 1998 ·The Journal of Organic Chemistry ·James A. Marshall,Michael R. Palovich	20
18	Comparative Studies on the Synthesis of an anti,syn Stereotriad with Chiral Allenylstannane and Allenylindium Reagents 1997 ·The Journal of Organic Chemistry ·James A. Marshall,Michael R. Palovich	27
19	Radical Cyclizations of Acylgermanes. New Reagent Equivalents of the Carbonyl Radical Acceptor Synthon 1997 ·Journal of the American Chemical Society ·Dennis P. Curran,Ulf Diederichsen,Michael R. Palovich	57
20	Approximate Absolute Rate Constants for 5-Exo and 6-Exo Cyclizations of 1°-Radicals to Acyl(triphenyl)germanes 1992 ·Synlett ·Dennis P. Curran,Michael R. Palovich	14

About Michael R. Palovich

Michael R. Palovich is a scholar working on Toxicology, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 22 papers that have together received 515 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (9 papers), Chemokine receptors and signaling (4 papers) and Neuropeptides and Animal Physiology (4 papers). The work is most often cited by research in Organic Chemistry (268 citations), Toxicology (21 citations) and Pharmaceutical Science (25 citations). Michael R. Palovich has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include James A. Marshall, Dennis P. Curran, Ulf Diederichsen, Miriam Burman, Henry M. Sarau, James J. Foley, Darren V. S. Green, Anthony J. Taylor, Paul L. Feldman and Paul D. Leeson. Their work appears in journals such as Journal of the American Chemical Society, The Journal of Physiology and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact